7461-86-1

Usage

Classification

Pharmaceutical compound

Function

Chelating agent

Mechanism of action

Binds and removes heavy metals from the body

Thiol group present

Allows formation of stable complexes with metals

Metals targeted

Lead, mercury, and cadmium

Aid in excretion

Helps in the removal of heavy metals from the body

Usage

Treatment of heavy metal poisoning

Application

Patients undergoing chemotherapy

Investigation for cystinuria treatment

A genetic disorder characterized by the formation of cystine kidney stones

Potential

Shown promise as a useful therapeutic agent for managing conditions related to heavy metal toxicity

Upstream product

• 147-93-3 Thiosalicylic acid 
• 598-72-1 2-Bromopropionic acid 
• 535-11-5 Ethyl 2-bromopropionate 
• 124-38-9 carbon dioxide 
• 622-38-8 Ethyl phenyl sulfide 
• 119-80-2 2,2'-dithiobenzoic acid 

Relevant academic research and scientific papers

Metallation Reactions. XVIII. Regioselective metallation of (alkylthio)benzenes by superbases

(Alkylthio)benzenes were monometallated at the alpha position by a stoichiometric mixture of butyllithium and potassium t-butoxide and bimetallated at both the alpha and the ortho positions by two equivalents of the same reagent.

Anti-inflammatory and analgesic 3-hydroxybenzo[b]thiophene derivatives, compositions, and method of use therefor

3-Hydroxybenzo[b]thiophene derivatives, such as 2-aralkyl, 2-alkyl and 2-alkenyl-3-hydroxybenzo[b]-thiophenes, were prepared by, among other methods, ring closure of 2-(2-carboxy-phenylthio)-α-substituted acetic acids. These compounds are found to be useful in the treatment of pain, fever, inflammation, arthritic conditions, asthma, allergic disorders, skin diseases, cardiovascular disorders, psoriasis, inflammatory diseases and other prostaglandin and/or leukotriene mediated diseases.